Adding to previous research on the gut-brain axis link to Parkinson's disease, researchers discovered the gut microbiome is involved with multiple pathways in the pathogenesis of Parkinson's.
People with schizophrenia have significantly higher rates of tandem repeats in their genome, up to 7% more than in people without the mental health disorder. The genes were primarily found in genes crucial to brain function.
Destruction or removal of the cilia in the striatum impairs time perception and judgment, new research suggests. The findings could have implications for a range of diseases including schizophrenia, ASD, and Parkinson's.
The number of daily stressors and people's reactivity to daily stressors decreases as we age, a new study reports.
Lecanemab, an amyloid-clearing monoclonal antibody drug shows positive results in the treatment of Alzheimer's disease. The drug is now poised for FDA approval early in 2023. Lecanemab slows cognitive decline by 27%.
The absence of certain gut bacteria causes mice to binge eat sweet, palatable foods. When the bacteria is restored, the desire to binge on sweetened foods decreases, and normal feeding patterns are resumed.
Those who score high for neuroticism and stress have a reduced risk of developing depression if they follow the five precepts of Buddhism, a new study reports.
Media coverage of the FDA-approved Alzheimer's drug aducanumab made the public less willing to volunteer in Alzheimer's pharmaceutical trials.
Social trauma impairs reward function in the brain, making social interaction no longer rewarding and triggering social avoidance.
Researchers report a link between adverse psychosocial factors experienced during childhood and cognitive function during midlife.